These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1883913)

  • 1. Effects of intracarotid and intravenous infusion of human TNF and LT on established intracerebral rat gliomas.
    Liu SK; Jakowatz JG; Pollack RB; Ceraldi C; Yamamoto R; Dett C; Lopez F; Camacho C; Carson WE; Sentovich SM
    Lymphokine Cytokine Res; 1991 Jun; 10(3):189-94. PubMed ID: 1883913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor effect of intra-arterial tumor necrosis factor-alpha in rats with transplanted intracerebral glioma and its evaluation by MRI].
    Harada K; Yoshida J; Wakabayashi T; Sugita K; Kurisu K; Uozumi T; Zieroth BF; Takahashi M; Yamanaka T
    No Shinkei Geka; 1995 Dec; 23(12):1069-74. PubMed ID: 8927213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
    Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
    J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor.
    Gridley DS; Li J; Kajioka EH; Andres ML; Moyers MF; Slater JM
    Anticancer Res; 2000; 20(6B):4195-203. PubMed ID: 11205248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-tumor activity of human recombinant TNF against human malignant glioma cell lines and combined effect with Hu INF-beta].
    Enomoto H; Yoshida J; Kageyama N; Ueda R; Kato T; Ota K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1953-61. PubMed ID: 3085596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha enhances antitumor effects of radiation against glioma xenografts.
    Gridley DS; Archambeau JO; Andres MA; Mao XW; Wright K; Slater JM
    Oncol Res; 1997; 9(5):217-27. PubMed ID: 9306429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS; Berger AE; Ware CF
    J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
    Pober JS; Lapierre LA; Stolpen AH; Brock TA; Springer TA; Fiers W; Bevilacqua MP; Mendrick DL; Gimbrone MA
    J Immunol; 1987 May; 138(10):3319-24. PubMed ID: 3494766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats.
    Carson WE; Jakowatz JG; Yamamoto R; Fitzgerald T; Gupta S; Vayuvegula B; Lucci JA; Beckman MT; Dulkanchainun S; Granger GA
    J Immunother (1991); 1991 Apr; 10(2):131-40. PubMed ID: 2043593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of tumor necrosis factor alpha after intravenous administration in rats. Dose dependence and influence of tumor necrosis factor beta.
    Zahn G; Greischel A
    Arzneimittelforschung; 1989 Sep; 39(9):1180-2. PubMed ID: 2590273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
    J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
    Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
    Browning J; Ribolini A
    J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment.
    Siesjö P; Visse E; Sjögren HO
    J Immunother Emphasis Tumor Immunol; 1996 Sep; 19(5):334-45. PubMed ID: 8941873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
    Janelidze S; Bexell D; Badn W; Darabi A; Smith KE; Fritzell S; Gunnarsson S; Milos P; Bengzon J; Salford LG; Siesjö P; Visse E
    J Immunother; 2009; 32(6):593-601. PubMed ID: 19483650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential usefulness of a cultured glioma cell line induced by Rous sarcoma virus in B10.A mouse as an immunotherapy model.
    Sakamoto K; Hoshino H; Kiuchi Y; Nakano G; Nagamachi Y
    Jpn J Exp Med; 1989 Oct; 59(5):173-80. PubMed ID: 2559217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-alpha gene and proton radiotherapy in an orthotopic brain tumor model.
    Gridley DS; Baer JR; Cao JD; Miller GM; Kim DW; Timiryasova TM; Fodor I; Slater JM
    Int J Oncol; 2002 Aug; 21(2):251-9. PubMed ID: 12118318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells.
    Fletcher WH; Shiu WW; Ishida TA; Haviland DL; Ware CF
    J Immunol; 1987 Aug; 139(3):956-62. PubMed ID: 3110292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.